New diabetes pill tested in japanese volunteers – early safety results expected
NCT ID NCT06869018
First seen Oct 01, 2025 · Last updated May 01, 2026 · Updated 26 times
Summary
This early-stage study tested an experimental oral drug called LY3549492 in 92 Japanese adults, some with type 2 diabetes and some healthy. The main goal was to check for side effects and see how the drug moves through the body. Researchers gave multiple doses and monitored participants for about 19 to 25 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Research Hospital Tokyo
Shinjuku-ku, 160-0004, Japan
-
Hakata Clinic
Fukuoka, 812-0025, Japan
-
Medical Corporation Heishinkai OPHAC Hospital
Osaka, 532-0003, Japan
-
P-One Clinic
Hachiōji, 192-0071, Japan
Conditions
Explore the condition pages connected to this study.